PF-Atlas › Clinical Trials › NCT00431964
Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis Not Infected With P. Aeruginosa
azithromycin 250 mg tablets · Phase 4
Registry ID
NCT00431964
Phase
Phase 4
Status
Completed
Drug / intervention
azithromycin 250 mg tablets
Sponsor
CF Therapeutics Development Network Coordinating Center
Start
2007-02
Enrollment
263
Locations
40
About this trial
This is a study to examine the safety, effect on lung function, and frequency of symptoms relating to cystic fibrosis during 24 weeks of treatment with the antibiotic azithromycin in 6-18 year-olds with CF who are not infected with Pseudomonas aeruginosa.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00431964 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.